These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10577620

  • 1. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
    Sundström I, Nyberg S, Bixo M, Hammarbäck S, Bäckström T.
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
    [Abstract] [Full Text] [Related]

  • 2. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S, Bäckström T, Zingmark E, Purdy RH, Poromaa IS.
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW, Sondheimer SJ, Rickels K.
    Psychopharmacol Bull; 1997 May; 33(2):303-9. PubMed ID: 9230648
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Buserelin in premenstrual syndrome.
    Hussain SY, Massil JH, Matta WH, Shaw RW, O'Brien PM.
    Gynecol Endocrinol; 1992 Mar; 6(1):57-64. PubMed ID: 1580169
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
    Wood SH, Mortola JF, Chan YF, Moossazadeh F, Yen SS.
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.
    Gerhardsen G, Hansen AV, Killi M, Fornitz GG, Pedersen F, Roos SB.
    Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441
    [Abstract] [Full Text] [Related]

  • 13. Premenstrual syndrome and related hormonal changes. Long-acting gonadotropin releasing hormone agonist treatment.
    Helvacioglu A, Yeoman RR, Hazelton JM, Aksel S.
    J Reprod Med; 1993 Nov; 38(11):864-70. PubMed ID: 8277482
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA.
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
    Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A.
    Obstet Gynecol; 2005 Sep; 106(3):492-501. PubMed ID: 16135578
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.